SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : eDrugstores: Drugstore.com, PlanetRx and Soma

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Davison who wrote (229)11/11/1999 1:42:00 PM
From: Tom D  Read Replies (1) of 254
 
PLRX beats expectations.

After the close of trading, PlanetRx.com (PLRX: news, msgs) posted a
narrower-than-expected pro forma net loss of $22.9 million, or 83 cents a
share, in the third quarter. Analysts surveyed by First Call expected a loss
of 97 cents. Revenue rose 308 percent to $3.1 million from $755,000
from the previous quarter. The online drugstore said membership increased
to 310,000 in the quarter, an sequential increase of 230,000. The San
Francisco-based company raised approximately $102 million in its stock
debut last month. Shares closed up 3/8 at 18 3/8.

I chose DSCM over PLRX because

1) PLRX does not have a bricks and mortar drugstore in its system. The way that DSCM gets reimbursement for 85 to 90% of prescriptions is through its relationship with Rite Aid.

2) DSCM appears to be getting their EDI into place faster than PLRX. In fact, it looks like DSCM is much more involved than any other eDrugstore in creating the NCPDP standards for ePrescribing.

And I agree that Rite Aid is a drag on DSCM, but I don't know how much.

I think this thread will take off in parallel with the rise of eDrugstores. Until then, I am content to trade emails with Firenze (who is one very smart dude) and anybody else who is interested.

Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext